Global Molecular Diagnostics Market & Future Forecast 2010 - 2014

Date: July 22, 2011
Price:
US$ 1,200.00
License [?]:
Publisher: Renub Research
Report type: Strategic Report
Delivery: E-mail Delivery (Word), CD-ROM Mail Delivery, Online Subscription, Hard Copy Mail Delivery, E-mail Delivery (PDF)
ID: G7E419B8736EN
Leaflet:

Download PDF Leaflet

Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The various application and technological sub-segments of molecular diagnostics are also giving the market a big push. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry.

Molecular diagnostics is a vital and dynamic field in which yesterday’s new technologies and platforms are today becoming populated with novel, diverse, and useful content. Growing with a CAGR of 19 percent global molecular diagnostics market is expected to reach US$ 15 Billion by 2014.The fastest growing segment is infectious disease with 21% market share as the dominant segment. The next fastest growing segment is oncology testing due to rising cases of cancer patients .The future growth is expected to come from genetic testing, blood screening testing and neurological testing.

Geographically, the US and EMEA markets are the most advanced in terms of adoption of molecular testing and make up the majority of the existing market. However, Japanese molecular diagnostics market is promising with the ageing population and a declining birth rate is putting the whole Japanese healthcare system under pressure. Under such circumstances, the role of preventive medical care is increasingly important. China and India molecular diagnostics market is one of the lucrative markets to rollout the diagnosis business. As with the rapid advancement Chinese and Indian economy has dramatically increased the purchasing power of a growing segment of the populace, which coupled with an emerging mindset toward wellness, preventive medicine, and access to cutting-edge products and services and makes the future outlook extremely positive for this very exciting new field in clinical care. The provision of new and cutting-edge molecular tests will surely be followed by greater affordability as prices come down due to return on investment, competition, and technology advancement.

Report Details

“Global Molecular Diagnostics Market & Future Forecast 2010 - 2014” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:
  • Global Molecular Diagnostics Market (2008 to 2014)
  • Top 8 application wise molecular diagnostics (Infectious Disease Testing, Blood Screening Testing, Oncology Testing, Genetic Testing, Tissue Typing Testing, Cardiovascular Disease Testing, Neurological Testing and Food Pathogen Detection Testing) data of Past, Present and Future Market (2008 to 2014)
  • Top 7 technological wise molecular diagnostics (PCR based tests, PCR related technologies, Non-PCR tests, FISH & Innovation testing, Biochips, Biosensor & Other technologies) data of Past, Present and Future Market (2008 to 2014)
  • Top 9 Countries (USA, Europe the Middle East & Africa , Japan, China, India, Germany, Brazil, Mexico and South Korea) data of Past, Present and Future Market
  • Mergers and Acquisitions in the molecular diagnostics market
  • Key drivers of growth in the molecular diagnostics market
  • Key Players in the molecular diagnostics market

Research Highlights
  • Globally, Molecular Diagnostics market is expected to reach US$ 15 Billion by 2014
  • Infectious disease testing dominates the molecular diagnostics market with more than 21% market share in 2010
  • Oncology and infectious disease testing sectors are likely growth leaders in the molecular diagnostics market
  • Blood Screening & Genetic testing will have a combined market share of 26% by 2014
  • Biochips market is expected to cross US$ 3 Billion by 2014
  • Fish & Innovation testing is expected to capture more than 16% market share by 2014
  • USA is expected to have more than US$ 6 Billion molecular diagnostics market by 2014

Key Players Analyzed

This section covers the key facts about the major players in molecular diagnostics market. The key players analyzed in this section are Roche, Abbott, Bayer AG, Qiagen, Gen-Probe, Becton Dickinson and Company, bioMérieux, Myriad Genetics, Inc., Celera Corporation.

Data Sources

Information and data in this report has been collected from various printable and non-printable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.
1. EXECUTIVE SUMMARY

2. GLOBAL – MOLECULAR DIAGNOSTICS MARKET & MARKET SHARES (APPLICATION WISE AND TECHNOLOGICAL WISE)

2.1 Molecular Diagnostics Market & Future Forecast
2.2 Molecular Diagnostics Market Share & Future Forecast (Application Segment)
2.3 Molecular Diagnostics Market Share & Future Forecast (Technologies Segment)

3. MOLECULAR DIAGNOSTICS MARKET (APPLICATION SEGMENT) – 2008 TO 2014

3.1 Infectious Disease Testing Market
  3.1.1 Virology Testing Market
  3.1.2 Haemagglutination-Inhibition Test (HAI) Testing
  3.1.3 Critical Care Infectious Testing Market
3.2 Blood Screening Market
3.3 Genetic Testing Market
3.4 Oncology Testing Market
3.5 Tissue Typing (HLA Testing) Market
3.6 Cardiovascular Disease Testing Market
3.7 Neurological Disorders Testing Market
3.8 Food Pathogen Detection Testing Market

4. MOLECULAR DIAGNOSTICS MARKET (TECHNOLOGIES SEGMENT) – 2008 TO 2014

4.1 PCR Based Test Market
4.2 PCR Related Technologies Market
4.3 Non-PCR Test Market
4.4 Fish & Innovations Testing Market (Fluorescent in-situ hybridization)
4.5 Biochips Market
4.6 Biosensors
4.7 Other Technologies Market

5. GEOGRAPHICAL DISTRIBUTION - MOLECULAR DIAGNOSTICS MARKET (2008 TO 2014)

5.1 United States Molecular Diagnostics Market
5.2 Europe, the Middle East & Africa (EMEA) Molecular Diagnostics Market
5.3 Germany Molecular Diagnostics Market
5.4 India Molecular Diagnostics Market
5.5 China Molecular Diagnostics Market
5.6 Japan Molecular Diagnostics Market
5.7 Brazil Molecular Diagnostics Market
5.8 Mexico Molecular Diagnostics Market
5.9 South Korea Molecular Diagnostics Market

6. GLOBAL MERGERS & ACQUISITIONS DEALS IN THE MOLECULAR DIAGNOSTICS SECTOR

7. KEY DRIVERS OF GROWTH IN GLOBAL MOLECULAR DIAGNOSTICS MARKET

7.1 Aging of the population
7.2 Re-Emergence of infectious threats (drug resistant TB, new strains of HIV, H1N1 & other flu)
7.3 Scientific and Technological Advancements

8. CHALLENGES

8.1 Reimbursement
8.2 The need for new Biomarker Assays
8.3 Regulatory Environment
8.4 Awareness and Acceptance

9. KEY PLAYERS

9.1 Roche
9.2 Abbott Laboratories
9.3 Qiagen
9.4 BD (Becton, Dickinson and Company)
9.5 biomerieux
9.6 Bayer AG
9.7 Gen-Probe
9.8 Myriad Genetics, Inc
9.9 Celera Corporation
9.10 Beckman Coulter

LIST OF FIGURES:

Figure 2 1: Global Molecular Diagnostics Market (Million US$), 2008 2010
Figure 2 2: Global Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 2 3: Global Segments of Molecular Diagnostics Market Share (Percent), 2008 2010
Figure 2 4: Global Forecast for Segments of Molecular Diagnostics Market Share (Percent), 2011 2014
Figure 2 5: Global Molecular Diagnostics Market Share Technologies wise (Percent), 2008 2010
Figure 2 6: Global Forecast for Molecular Diagnostics Market Share Technologies wise (Percent), 2011 2014
Figure 3 1: Global Infectious Disease Testing Market (Million US$), 2008 2010
Figure 3 2: Global Forecast for Infectious Disease Testing Market (Million US$), 2011 2014
Figure 3 3: Global Virology Testing Market (Million US$), 2007 2010
Figure 3 4: Global Forecast for Virology Testing Market (Million US$), 2011 2014
Figure 3 5: Global HAI Testing Market (Million US$), 2008 2010
Figure 3 6: Global Forecast for HAI Testing Market (Million US$), 2011 2014
Figure 3 7: Global Critical Care Infectious Testing Market (Million US$), 2008 2010
Figure 3 8: Global Forecast for Critical Care Infectious Testing Market (Million US$), 2011 2014
Figure 3 9: Global Blood Screening Market (Million US$), 2007 2010
Figure 3 10: Global Forecast for Blood Screening Market (Million US$), 2011 2014
Figure 3 11: Global Genetic Testing Market (Million US$), 2007 2010
Figure 3 12: Global Forecast for Genetic Testing Market (Million US$), 2011 2014
Figure 3 13: Global Oncology Market (Million US$), 2007 2010
Figure 3 14: Global Forecast for Oncology Market (Million US$), 2011 2014
Figure 3 15: Global Tissue Typing Market (Million US$), 2008 2010
Figure 3 16: Global Forecast for Tissue Typing Market (Million US$), 2011 2014
Figure 3 17: Global Cardiovascular Disease Testing Market (Million US$), 2005 2010
Figure 3 18: Global Forecast for Cardiovascular Disease Testing Market (Million US$), 2011 2014
Figure 3 19: Global Neurological Disorders Testing Market (Million US$), 2005 2010
Figure 3 20: Global Forecast for Neurological Disorders Testing Market (Million US$), 2011 2014
Figure 3 21: Global Food Pathogen Detection Testing Market (Million US$), 2005 2010
Figure 3 22: Global Forecast for Food Pathogen Detection Testing Market (Million US$), 2011 2014
Figure 4 1: Global PCR Based Test Market (Million US$), 2005 2010
Figure 4 2: Global Forecast for PCR Based Test Market (Million US$), 2011 2014
Figure 4 3: Global PCR Related Technologies Market (Million US$), 2005 2010
Figure 4 4: Global Forecast for PCR Related Technologies Market (Million US$), 2011 2014
Figure 4 5: Global Non-PCR Test Market (Million US$), 2005 2010
Figure 4 6: Global Non-PCR Test Market (Million US$), 2011 2014
Figure 4 7: Global Fish & Innovations Market (Million US$), 2005 2010
Figure 4 8: Global Forecast for Fish & Innovations Market (Million US$), 2011 2014
Figure 4 9: Global Biochips/ Microarrays Market (Million US$), 2005 2010
Figure 4 10: Global Forecast for Biochips/Micrroarrays Market (Million US$), 2011 2014
Figure 4 11: Global Biosensors Market (Million US$), 2005 2010
Figure 4 12: Global Forecast for Biosensors Market (Million US$), 2011 2014
Figure 4 13: Global Other Technologies Market (Million US$), 2005 2010
Figure 4 14: Global Forecast for Other Technologies Market (Million US$), 2011 2014
Figure 5 1: US Molecular Diagnostics Market (Million US$), 2002 2010
Figure 5 2: US Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 3: EMEA Molecular Diagnostics Market (Million US$), 2007 2010
Figure 5 4: EMEA Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 5: Germany Molecular Diagnostics Market (Million US$), 2009 2010
Figure 5 6: Germany Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 7: India Molecular Diagnostics Market (Million INR), 2006 2010
Figure 5 8: India Forecast for Molecular Diagnostics Market (Million INR), 2011 2014
Figure 5 9: China Molecular Diagnostics Market (Million US$), 2004, 2007 2010
Figure 5 10: China Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 11: Japan Molecular Diagnostics Market (Million US$), 2007 2010
Figure 5 12: Japan Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 13: Brazil Molecular Diagnostics Market (Million US$), 2007 2010
Figure 5 14: Brazil Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 15: Mexico Molecular Diagnostics Market (Million US$), 2007 2010
Figure 5 16: Mexico Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 5 17: South Korea Molecular Diagnostics Market (Million US$), 2005 2010
Figure 5 18: South Korea Forecast for Molecular Diagnostics Market (Million US$), 2011 2014
Figure 7 1: Global Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050
Figure 7 2: Old age Dependency Ratio: Major Areas, 2009 & 2050

LIST OF TABLES:

Table 6 1: Global Mergers & Acquisitions Deals in the Molecular Diagnostics Sector (Million US$) 2006 2010
Table 7 1: Global Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009
Table 9 1: Roche Key Financials (Million US$) 2008 2010
Table 9 2: Abbott Laboratories Key Financials (Million US$) 2008 2010
Table 9 3: Qiagen Key Financials (Million US$) 2008 2010
Table 9 4: BD (Becton, Dickinson and Company) Key Financials (Million US$) 2008 2010
Table 9 5: Biomerieux Key Financials (Million US$) 2008 2010
Table 9 6: Bayer AG Key Financials (Million US$) 2008 2010
Table 9 7: Gen Probe Key Financials (Million US$) 2008 2010
Table 9 8: Myriad Genetics, Inc. Key Financials (Million US$) 2008 2010
Table 9 9: Celera Corporation Key Financials (Million US$), 2008 2010
Table 9 10: Beckman Coulter Key Financials (Million US$) 2008 2010
Skip to top


Ask Your Question

Global Molecular Diagnostics Market & Future Forecast 2010 - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: